Hyaluronic Acid As a Modern Approach in Anticancer Therapy-Review

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Jan 8

PMID 36613567

Authors

Monika Michalczyk

Ewelina Humeniuk

Grzegorz Adamczuk

Agnieszka Korga-Plewko

Affiliations

Soon will be listed here.

Abstract

Hyaluronic acid (HA) is a linear polysaccharide and crucial component of the extracellular matrix (ECM), maintaining tissue hydration and tension. Moreover, HA contributes to embryonic development, healing, inflammation, and cancerogenesis. This review summarizes new research on the metabolism and interactions of HA with its binding proteins, known as hyaladherins (CD44, RHAMM), revealing the molecular basis for its distinct biological function in the development of cancer. The presence of HA on the surface of tumor cells is a sign of an adverse prognosis. The involvement of HA in malignancy has been extensively investigated using cancer-free naked mole rats as a model. The HA metabolic components are examined for their potential impact on promoting or inhibiting tumor formation, proliferation, invasion, and metastatic spread. High molecular weight HA is associated with homeostasis and protective action due to its ability to preserve tissue integrity. In contrast, low molecular weight HA indicates a pathological condition in the tissue and plays a role in pro-oncogenic activity. A systematic approach might uncover processes related to cancer growth, establish novel prognostic indicators, and identify potential targets for treatment action.

Citing Articles

Advancements in Hyaluronic Acid Effect in Alveolar Ridge Preservation: A Narrative Review.

Nistor P, Candea A, Micu I, Soanca A, Caloian C, Bardea A Diagnostics (Basel). 2025; 15(2).

PMID: 39857021 PMC: 11763514. DOI: 10.3390/diagnostics15020137.

Utilisation of High Molecular Weight and Ultra-High Molecular Weight Hyaluronan in Management of Glioblastoma.

Salagean A, Moldovan C, Slevin M Gels. 2025; 11(1).

PMID: 39852021 PMC: 11764969. DOI: 10.3390/gels11010050.

How to Fabricate Hyaluronic Acid for Ocular Drug Delivery.

Kim M, Jung M, Lee D, Ahn S, Lee G, Park C Pharmaceutics. 2025; 16(12.

PMID: 39771582 PMC: 11680071. DOI: 10.3390/pharmaceutics16121604.

Production of Hyaluronidase by .

Janpan P, Schmelzer B, Klamrak A, Tastub P, Upathanpreecha T, Rahman S J Fungi (Basel). 2024; 10(12).

PMID: 39728350 PMC: 11676926. DOI: 10.3390/jof10120854.

Lutein derived from Xenostegia tridentata exhibits anticancer activities against A549 lung cancer cells via hyaluronidase inhibition.

Chatwichien J, Semakul N, Yimklan S, Suwanwong N, Naksing P, Ruchirawat S PLoS One. 2024; 19(12):e0315570.

PMID: 39680591 PMC: 11649105. DOI: 10.1371/journal.pone.0315570.

References

St Croix B, Man S, Kerbel R . Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors. Cancer Lett. 1998; 131(1):35-44. DOI: 10.1016/s0304-3835(98)00199-2. View

Shuster S, Frost G, Csoka A, Formby B, Stern R . Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int J Cancer. 2002; 102(2):192-7. DOI: 10.1002/ijc.10668. View

Wu Y, Zhao Q, Peng C, Sun L, Li X, Kuang D . Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J Pathol. 2011; 225(3):438-47. DOI: 10.1002/path.2947. View

Pure E, Assoian R . Rheostatic signaling by CD44 and hyaluronan. Cell Signal. 2009; 21(5):651-5. PMC: 2650006. DOI: 10.1016/j.cellsig.2009.01.024. View

Karbownik M, Nowak J . Hyaluronan: towards novel anti-cancer therapeutics. Pharmacol Rep. 2014; 65(5):1056-74. DOI: 10.1016/s1734-1140(13)71465-8. View

Whatcott C, Han H, Posner R, Hostetter G, Von Hoff D . Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look. Cancer Discov. 2011; 1(4):291-6. PMC: 3204883. DOI: 10.1158/2159-8290.CD-11-0136. View

Tian X, Azpurua J, Ke Z, Augereau A, Zhang Z, Vijg J . INK4 locus of the tumor-resistant rodent, the naked mole rat, expresses a functional p15/p16 hybrid isoform. Proc Natl Acad Sci U S A. 2015; 112(4):1053-8. PMC: 4313802. DOI: 10.1073/pnas.1418203112. View

Zhao Y, Qiao S, Shi S, Yao L, Hou X, Li C . Modulating Three-Dimensional Microenvironment with Hyaluronan of Different Molecular Weights Alters Breast Cancer Cell Invasion Behavior. ACS Appl Mater Interfaces. 2017; 9(11):9327-9338. DOI: 10.1021/acsami.6b15187. View

Takaishi S, Okumura T, Tu S, Wang S, Shibata W, Vigneshwaran R . Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009; 27(5):1006-20. PMC: 2746367. DOI: 10.1002/stem.30. View

10.

Fallacara A, Baldini E, Manfredini S, Vertuani S . Hyaluronic Acid in the Third Millennium. Polymers (Basel). 2019; 10(7). PMC: 6403654. DOI: 10.3390/polym10070701. View

11.

Wang S, Earle C, Wong G, Bourguignon L . Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression. Head Neck. 2012; 35(4):511-20. DOI: 10.1002/hed.22991. View

12.

Kim P, Halbrook C, Kerk S, Radyk M, Wisner S, Kremer D . Hyaluronic acid fuels pancreatic cancer cell growth. Elife. 2021; 10. PMC: 8730721. DOI: 10.7554/eLife.62645. View

13.

Simpson M . Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice. Am J Pathol. 2006; 169(1):247-57. PMC: 1698770. DOI: 10.2353/ajpath.2006.060032. View

14.

Suzuki M, Kobayashi H, Kanayama N, Nishida T, Takigawa M, Terao T . CD44 stimulation by fragmented hyaluronic acid induces upregulation and tyrosine phosphorylation of c-Met receptor protein in human chondrosarcoma cells. Biochim Biophys Acta. 2002; 1591(1-3):37-44. DOI: 10.1016/s0167-4889(02)00246-x. View

15.

Lokeshwar V, Mirza S, Jordan A . Targeting hyaluronic acid family for cancer chemoprevention and therapy. Adv Cancer Res. 2014; 123:35-65. PMC: 4791948. DOI: 10.1016/B978-0-12-800092-2.00002-2. View

16.

Tan J, Wang X, Su X, Li H, Shi Y, Wang L . Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis. PLoS One. 2011; 6(7):e22836. PMC: 3145763. DOI: 10.1371/journal.pone.0022836. View

17.

Davidson B, Trope C, Reich R . The role of the tumor stroma in ovarian cancer. Front Oncol. 2014; 4:104. PMC: 4026708. DOI: 10.3389/fonc.2014.00104. View

18.

Zahalka M, Okon E, Gosslar U, Holzmann B, Naor D . Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J Immunol. 1995; 154(10):5345-55. View

19.

Garin T, Rubinstein A, Grigoriadis N, Nedvetzki S, Abramsky O, Mizrachi-Koll R . CD44 variant DNA vaccination with virtual lymph node ameliorates experimental autoimmune encephalomyelitis through the induction of apoptosis. J Neurol Sci. 2007; 258(1-2):17-26. DOI: 10.1016/j.jns.2007.01.079. View

20.

Slomiany M, Dai L, Tolliver L, Grass G, Zeng Y, Toole B . Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides. Clin Cancer Res. 2009; 15(24):7593-7601. PMC: 2794991. DOI: 10.1158/1078-0432.CCR-09-2317. View